EPISODE · Aug 21, 2026 · 7 MIN
今天3分钟我们来聊聊mRNA癌症疫苗取得重大突破
from 源于细胞BioInsid的个人播客
本期播客解读Moderna mRNA癌症疫苗III期临床成功的核心意义，详解其作用原理、试验数据，介绍AI在其中的关键作用，同时梳理该技术的后续应用前景与现存挑战。参考文献：Moderna & Merck. INTerpath-001 III期临床达到主要终点公告. 2026-08-19The Lancet. KEYNOTE-942/mRNA-4157-P201 IIb期随机对照试验. 2024Journal of Clinical Oncology. KEYNOTE-942五年随访数据. 2026-01凤凰网科技. Moderna的mRNA癌症疫苗，到底是突破还是炒作. 2026-08-20今日头条. Moderna一天涨177%：改写mRNA命运的黑色素瘤破局战. 2026-08-20前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊mRNA癌症疫苗取得重大突破
0:00
7:15
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 7 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on August 21, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!